Phase III trial of alvimopan, a novel, peripherally acting, Mu opioid antagonist, for postoperative ileus after major abdominal surgery: Commentary

Diseases of the Colon and Rectum

Volumn 48, Issue 6, 2005, Pages 1125-1129

  Fischer, Josef E ^a   Delaney, Conor P ^a   Weese, James L ^a   Hyman, Neil H ^a   Bauer, Joel ^a   Techner, Lee ^a   Gabriel, Kathie ^a   Du, Wei ^a   Schmidt, William K ^a   Wallin, Bruce A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALVIMOPAN; MU OPIATE RECEPTOR ANTAGONIST; OPIATE; PLACEBO; ROFECOXIB;

CANCER SURGERY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIVERTICULITIS; DOSE RESPONSE; DRUG EFFICACY; EPIDURAL ANESTHESIA; FOOD INTAKE; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYSTERECTOMY; ILEUS; INTENSIVE CARE; INTESTINE RESECTION; LAPAROTOMY; NASOGASTRIC TUBE; NAUSEA; NOTE; PNEUMONIA; REFLUX ESOPHAGITIS; STATISTICAL ANALYSIS;

EID: 21244471583     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)